Astrana Health (NASDAQ:ASTH) Reaches New 12-Month Low - Should You Sell?

Shares of Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) reached a new 52-week low on Friday . The company traded as low as $32.54 and last traded at $32.83, with a volume of 53825 shares trading hands. The stock had previously closed at $33.53.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on ASTH shares. Macquarie upgraded Astrana Health to a "hold" rating in a research note on Monday, December 16th. TD Cowen assumed coverage on shares of Astrana Health in a research report on Monday, October 14th. They set a "buy" rating and a $66.00 price target on the stock. Robert W. Baird lifted their price objective on shares of Astrana Health from $67.00 to $86.00 and gave the company an "outperform" rating in a research report on Wednesday, November 13th. BTIG Research boosted their price objective on shares of Astrana Health from $60.00 to $70.00 and gave the stock a "buy" rating in a research note on Thursday, October 3rd. Finally, KeyCorp initiated coverage on shares of Astrana Health in a report on Friday, October 11th. They issued a "sector weight" rating on the stock. Two equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $65.17.

Astrana Health Trading Down 2.4 %

The company has a market cap of $1.84 billion, a price-to-earnings ratio of 25.17, a PEG ratio of 1.80 and a beta of 1.13. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. The business's 50 day moving average price is $45.01 and its 200-day moving average price is $47.61.

Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its quarterly earnings data on Thursday, November 7th. The company reported $0.33 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.33. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The firm had revenue of $478.71 million during the quarter, compared to the consensus estimate of $462.01 million. During the same period last year, the business posted $0.47 earnings per share. On average, equities analysts anticipate that Astrana Health, Inc. will post 1.16 EPS for the current fiscal year.

Institutional Trading of Astrana Health

Institutional investors have recently added to or reduced their stakes in the company. GAMMA Investing LLC acquired a new stake in shares of Astrana Health during the third quarter worth $34,000. Nisa Investment Advisors LLC bought a new position in Astrana Health during the third quarter worth about $35,000. KBC Group NV acquired a new stake in Astrana Health in the 3rd quarter worth about $70,000. Quarry LP bought a new stake in Astrana Health in the 3rd quarter valued at about $77,000. Finally, Quest Partners LLC acquired a new position in shares of Astrana Health during the 3rd quarter worth approximately $133,000. 52.77% of the stock is currently owned by institutional investors.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.